Sangamo Therapeutics, Inc. (SGMO): Price and Financial Metrics
SGMO Price/Volume Stats
| Current price | $2.47 | 52-week high | $3.18 |
| Prev. close | $2.31 | 52-week low | $0.30 |
| Day low | $2.25 | Volume | 13,730,300 |
| Day high | $2.53 | Avg. volume | 6,941,393 |
| 50-day MA | $1.94 | Dividend yield | N/A |
| 200-day MA | $0.98 | Market Cap | 515.36M |
SGMO Stock Price Chart Interactive Chart >
Sangamo Therapeutics, Inc. (SGMO) Company Bio
Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for various monogenic and infectious diseases with unmet medical needs. The company was founded in 1995 and is based in Richmond, California.
SGMO Price Returns
| 1-mo | 26.02% |
| 3-mo | 157.24% |
| 6-mo | 425.76% |
| 1-year | 487.54% |
| 3-year | -70.49% |
| 5-year | -72.40% |
| YTD | 354.63% |
| 2023 | -82.70% |
| 2022 | -58.13% |
| 2021 | -51.94% |
| 2020 | 86.44% |
| 2019 | -27.09% |
Continue Researching SGMO
Want to see what other sources are saying about Sangamo Therapeutics Inc's financials and stock price? Try the links below:Sangamo Therapeutics Inc (SGMO) Stock Price | Nasdaq
Sangamo Therapeutics Inc (SGMO) Stock Quote, History and News - Yahoo Finance
Sangamo Therapeutics Inc (SGMO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...